Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Department of Rare/Intractable Cancer Analysis Research, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Pediatr Surg Int. 2022 Dec;38(12):1821-1827. doi: 10.1007/s00383-022-05235-7. Epub 2022 Sep 14.
It is important for patients with biliary atresia (BA) to retain the native liver after Kasai portoenterostomy (PE). Laparoscopic PE (Lap-PE) is standard, whereas laparoscopic revision of PE (Lap-revision) is performed as needed. We report the medium-term outcomes of Lap-revision.
We retrospectively reviewed the demographics and outcomes of 63 patients who underwent Lap-PE between 2013 and 2021. Indications for revision included recurrent jaundice, repeat cholangitis, and persistent jaundice with temporary biliary excretion following the initial PE. We compared liver transplantation (LT) data of patients who underwent Lap-revision with those of patients who did not.
Lap-revision was performed in 20 patients. Of those 17 (excluding the two who were jaundice-free before the age of 1, and the one who underwent open conversion for bleeding), 11 (65%) were jaundice-free 1 year after Lap-revision. The surgical parameters of LT did not differ between patients who underwent Lap-revision and those who did not.
Lap-revision for patients with BA had a limited but positive effect on native liver survival and did not adversely affect subsequent LT. Therefore, Lap-revision could be second-line standard therapy in patients with BA who have demonstrated biliary drainage at least once after initial PE.
对于胆道闭锁(BA)患者来说,在进行 Kasai 胆管空肠吻合术(PE)后保留其原有肝脏非常重要。腹腔镜 PE(Lap-PE)是标准术式,而腹腔镜 PE 修正术(Lap-revision)则根据需要进行。我们报告了 Lap-revision 的中期结果。
我们回顾性分析了 2013 年至 2021 年间接受 Lap-PE 的 63 例患者的人口统计学和结局数据。修正术的适应证包括复发性黄疸、反复胆管炎以及初次 PE 后出现暂时性胆汁排出的持续黄疸。我们比较了接受 Lap-revision 的患者和未接受 Lap-revision 的患者的肝移植(LT)数据。
有 20 例患者接受了 Lap-revision。在这 17 例患者中(不包括 2 例在 1 岁前黄疸消退的患者和 1 例因出血行开放转换的患者),11 例(65%)在 Lap-revision 后 1 年黄疸消退。接受 Lap-revision 和未接受 Lap-revision 的患者的 LT 手术参数没有差异。
对于 BA 患者,Lap-revision 对其原有肝脏的存活率有一定但积极的影响,并且不会对后续的 LT 产生不利影响。因此,对于至少在初次 PE 后有过一次胆道引流的 BA 患者,Lap-revision 可以作为二线标准治疗。